Find a Tender
complete
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS Wales Shared Services Partnership: "Supply of Vagal Nerve Stimulators". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | NHS Wales Shared Services Partnership | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: NHS Wales Shared Services Partnership
Market Analytics
Derived from OCDS awards & bid statistics
Published history for NHS Wales Shared Services Partnership. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
1Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 7 active published awards; 1 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityNHS Wales Shared Services Partnership | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published5 Oct 2021, 12:24 BST | Last source update5 Oct 2021, 12:24 BST | Recurring procurementNot published |
ClassificationStimulator | ||
Delivery area | ||
OCIDocds-h6vhtk-02e809 | ||
What is being bought
NHS Wales Shared Services Partnership wish to inform the market that they intend to award a contract for the supply of Vagal Nerve Stimulators.
What changed
From the official release history
- Status changed to complete
5 Oct 2021, 12:24 BST - Official notice release published
5 Oct 2021, 12:24 BST - Buyer information updated
5 Oct 2021, 12:24 BST
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedStatus not publishedPublished valueNot publishedNHS Wales Shared Services Partnership, on behalf of Cardiff and Vale University Local Health Board wish to inform the market that they intend to award a six month contract with option to extend for up to a further six months for the supply of Vagal Nerve Stimulators.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
5 Oct 2021, 12:24 BST - Award active
Not published · Not published - Contract active
Signed 5 Oct 2021, 00:00 BST · £350,000
Commercial outcome and competition
Awards LivaNova UK Ltd Not published · Not published · active |
Contracts Contract £350,000 · signed 5 Oct 2021, 00:00 BST · active |
Bid statisticsNo aggregate bid statistics published |
Buyer and organisations in this procedure
NHS Wales Shared Services Partnership
Contracting authority GB-FTS-30485Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published
Planning and rationale
Planning budgetNot published |
No-engagement rationaleNot published |
Procedure rationaleVNS Therapy is delivered through an implanted device that sends mild pulses to the vagus nerve at regular intervals throughout the day in an effort to reduce and/or prevent seizures. Patients are referred to this type of therapy when drugs have failed to provide a more manageable treatment. These devices are programmeable for a personalised therapy approach and the technology is highly specialised. Livanova are the only company that manufacture and supply this device and as such, the Health Board is applying a 10 day standstill period prior to awarding this contract. |